Attached files

file filename
8-K - SKYSTAR BIO-PHARMACEUTICAL COv205591_8k.htm
EX-99.1 - SKYSTAR BIO-PHARMACEUTICAL COv205591_ex99-1.htm
 
 
December 17, 2010
 
Securities and Exchange Commission
405 Fifth Street, NW
Washington, D.C. 20549
 
Gentlemen:
 
We have read Item 4.01, and are in agreement with the statements as they related to our firm being made by Skystar Bio-Pharmaceutical Company in Item 4.01 of its Form 8-K dated December 17, 2010, captioned “Changes in Registrant’s Certifying Accountant.”  We have no basis to agree or disagree with the other statements contained therein.
 
/s/ Frazer Frost, LLP
 
135 South State College Boulevard, Suite 300 | Brea, California 92821 | 714.990.1040 | frazerfrost.com
 
Los Angeles and Visalia, CA | Little Rock and Fayetteville, AR | Raleigh, NC
 
FRAZER FROST, LLP is an independent firm associated with Moore Stephens International Limited.